ShervinTabriziMD

Ocular Radiation Oncology

Attending Physician, Radiation Oncology

Dr. Tabrizi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2018 - 2022
Brigham and Womens HospitalInternship, Preliminary Year, 2017 - 2018
Harvard Medical SchoolClass of 2017

PubMed

180 citations
Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq
Dylan Kotliar, Adrian Veres, M. Aurel Nagy, Shervin Tabrizi, Eran Hodis
Elife. 2019-07-08
145 citations
Lassa Fever in Post-Conflict Sierra Leone
Jeffrey G. Shaffer, Donald S. Grant, John S. Schieffelin, Matthew L. Boisen, Augustine Goba
Plos Neglected Tropical Diseases. 2014-03-20
89 citations
Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study.
Peter O. Okokhere, Andrés Colubri, Chukwuemeka O Azubike, Christopher Ojemiega Iruolagbe, Omoregie O Osazuwa
The Lancet. Infectious Diseases. 2018-06-01

Injectable Agents Could Improve Liquid Biopsy for Cancer Detection and MonitoringJanuary 20th, 2024
Research Spotlight: A Two-Part Priming Strategy to Increase the Sensitivity of Liquid BiopsiesFebruary 1st, 2024
Researchers Uncover Genetic Factors for Severe Lassa FeverFebruary 14th, 2024